Search for


TEXT SIZE

search for



떒諛깅㈃뿭寃궗 봽濡쒓렇옩 떊鍮숇룄議곗궗 寃곌낵蹂닿퀬(2017)
Annual Report on the External Quality Assessment Scheme for Special Protein in Korea (2017)
J Lab Med Qual Assur 2018;40:85-91
Published online June 30, 2018
© 2018 Korean Association of External Quality Assessment Service.

諛뺥삎몢
Hyung-Doo Park

꽦洹좉븰援 쓽怨쇰븰 궪꽦꽌슱蹂묒썝 吏꾨떒寃궗쓽븰怨

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Correspondence to: Hyung-Doo Park Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: +82-2-3410-0290 Fax: +82-2-3410-2719 E-mail: nayadoo@hanmail.net
援먯떊옄: 諛뺥삎몢 슦)06351 꽌슱떆 媛뺣궓援 씪썝濡 81, 꽦洹좉븰援 궪꽦꽌슱蹂묒썝 吏꾨떒寃궗쓽븰怨 Tel: 02)3410-0290, Fax: 02)3410-2719, E-mail: nayadoo@hanmail.net
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Abstract

2017뀈 븳엫긽寃궗젙룄愿由ы삊쉶 떊鍮숇룄議곗궗궗뾽뿉꽌 떒諛깅㈃뿭寃궗봽濡쒓렇옩 珥 9媛쒖쓽 젙웾寃궗빆紐⑹쑝濡 援ъ꽦릺뿀怨 뿰 2쉶뿉 嫄몄퀜 쉶李⑤퀎濡 3媛쒖쓽 젙룄愿由щЪ吏덉씠 씠슜릺뿀떎. 媛 湲곌뿉꽌 엯젰맂 媛 寃궗빆紐⑹뿉 븳 젙蹂댁 寃곌낵瑜 湲곕컲쑝濡 寃궗湲곌린뿉 뵲씪 遺꾩꽍븯떎. 蹂닿퀬꽌뒗 쟾泥 李몄뿬湲곌쓽 듅꽦쓣 蹂댁뿬二쇰뒗 怨듯넻蹂닿퀬꽌 媛쒕퀎湲곌쓽 룊媛옄猷뚮 蹂댁뿬二쇰뒗 湲곌蹂 蹂닿퀬꽌濡 굹늻뼱 옉꽦븯떎. 젣떆맂 넻怨꾩뿉뒗 媛 洹몃9蹂 李몄뿬湲곌 닔, 룊洹, 몴以렪李, 蹂룞怨꾩닔, 以묒븰媛, 理쒖냼媛믨낵 理쒕媛믪씠 룷븿릺룄濡 븯怨 媛쒕퀎蹂닿퀬꽌뒗 媛 寃궗빆紐⑸퀎濡 넻怨꾩튂瑜 蹂댁뿬二쇰뒗 몴, 엳뒪넗洹몃옩怨 젅鍮-젣떇뒪 李⑦듃濡 援ъ꽦릺룄濡 븯떎. 넻怨꾩튂瑜 젣떆븳 몴뿉뒗 媛 湲곌쓽 寃곌낵媛믨낵 媛 遺꾨쪟蹂 넻怨꾩튂瑜 젣떆븯怨 湲곗遺꾨쪟 꽭 遺꾨쪟뿉꽌뒗 몴以렪李⑥닔瑜 븿猿 젣떆븯떎. 李몄뿬湲곌쓽 닔 寃궗옣鍮꾩쓽 遺꾪룷뿉 엳뼱꽌뒗 쟾泥댁쟻쑝濡 쟾뀈룄 겙 李⑥씠뒗 뾾뿀怨, 媛 寃궗빆紐⑸퀎 쉶李⑤퀎濡 젙룄愿由щЪ吏덉쓽 냽룄媛 궙怨 李몄뿬湲곌쓽 닔媛 쟻쓣닔濡 蹂씠怨꾩닔뒗 긽쟻쑝濡 넂 寃쏀뼢쓣 蹂댁떎. 媛 湲곌뿉꽌 쇅遺젙룄愿由 寃곌낵瑜 빐꽍븯怨 떒諛깅㈃뿭 寃궗옣鍮꾨 꽑깮븷 븣씠젴넻怨꾨텇꽍 옄猷뚭쑀슜븷젴 寃껋쑝濡 깮媛곹븳떎.

In 2017, the Korean Association of External Quality Assessment Service developed a special protein proficiency testing program that consisted of nine quantitative test items. This program was conducted twice a year using three-level control materials. Data and results of each test item were analyzed by respective institutions according to the test instruments. The report was prepared by dividing it into a common report that showed the characteristics of all the participating institutions and an organization-specific report that showed the assessment data of individual institutions. The following statistical data were presented: the number of participating institutions per group, mean, standard deviation, coefficient of variation, median, minimum value, and maximum value. The individual report was composed of a table, histogram, and Levey-Jennings chart showing the statistics for each test item. The results of the assessment of each institution and the statistical data for each classification are presented in a table, and a standard deviation index for both the company classification and classification by instruments was provided. Overall, no significant difference was observed between the number of participating institutions and the distribution of test equipment. The coefficient of variation tended to be relatively high for each test item because the concentration of quality control materials was low and the number of participating institutions was small. I believe that these statistical analysis data are useful for analyzing external quality control results of the institutions and selecting an immunoassay test instrument for special protein.

Keywords : Korean Association of External Quality Assessment Service, Laboratory proficiency testing, Special protein
꽌 濡

븳엫긽寃궗젙룄愿由ы삊쉶뿉꽌뒗 2016뀈遺꽣 깉濡쒖슫 諛⑹떇쓽 李⑥꽭 떊鍮숇룄議곗궗궗뾽쓣 떆뻾븯뒗뜲, 媛옣 겙 蹂솕뒗 湲곗〈쓽 遺꾧낵 以묒떖 슫쁺泥닿퀎뿉꽌 6媛 遺꾨쪟, 46媛 봽濡쒓렇옩 떒쐞蹂 슫쁺泥닿퀎濡 쟾솚븯뿬 寃궗빆紐⑹쓣 꽭遺꾪솕븳 젏씠떎. 엫긽솕븰 遺꾩빞뒗 씪諛섑솕븰寃궗봽濡쒓렇옩쓣 鍮꾨’븯뿬 떒諛깅㈃뿭寃궗, 샇瑜대が寃궗 벑 21媛쒖쓽 봽濡쒓렇옩쑝濡 援ъ꽦릺뿀뒗뜲, 씠 以묒뿉뒗 湲곗〈 泥닿퀎븯뿉 엫긽솕븰遺꾧낵쐞썝쉶뿉꽌 떞떦빐 솕뜕 씪諛섑솕븰寃궗 遺꾩빞, 떦솕삁깋냼, 吏吏 諛 겕젅븘떚땶뿉 븳 젙솗룄 湲곕컲 떊鍮숇룄議곗궗궗뾽 벑씠 룷븿릺뼱 엳떎[1-4]. 떒諛깅㈃뿭寃궗봽濡쒓렇옩뿉꽌 떆뻾릺뒗 寃궗빆紐⑹ ceruloplasmin쓣 룷븿븳 9媛吏濡 꽑젙릺뿀떎. 씠뿉 2017뀈 李⑥꽭 떊鍮숇룄議곗궗궗뾽쑝濡 떎떆릺뿀뜕 떒諛깅뿭寃궗뿉 븳 떊鍮숇룄議곗궗궗뾽 寃곌낵瑜 遺꾩꽍븯뿬 蹂닿퀬븯怨좎옄 븳떎.

옱猷 諛 諛⑸쾿

1. 긽

떒諛깅㈃뿭寃궗봽濡쒓렇옩 뿰 2쉶뿉 嫄몄퀜 쉶李⑤퀎濡 3媛쒖쓽 젙룄愿由щЪ吏덉쓣 궗슜븯뿬 닔뻾릺뿀떎. 젙룄愿由щЪ吏덉 깋옣긽깭媛 쑀吏맆 닔 엳룄濡 븘씠뒪뙥씠 궡옣맂 듅닔 젣옉諛뺤뒪뿉 꽔뼱 李몄뿬벑濡앷린愿쓣 긽쑝濡 5썡 15씪(1李)怨 10썡 16씪(2李)뿉 媛곴컖 諛쒖넚릺뿀떎(Table 1).

Table 1 . Baseline data used in proficiency tests for special protein in 2017.

꺿꺿긘ariableTrial

1st2nd
Delivery date2017. 5. 152017. 10. 16
Response date2017. 5. 155. 262017. 10. 1610. 27
Test
귺lpha1-antitrypsin77
귺nti-streptolysin O (quantitative)165168
귺nti-streptolysin O (qualitative)7681
귺nti-streptolysin O (semi-quantitative)34
귽eruloplasmin1414
귽-reactive protein (quantitative)406464
귽-reactive protein (qualitative)4864
긃erritin281295
긅aptoglobin3535
긑realbumin2624
긓heumatoid factor (quantitative)334363
긓heumatoid factor (qualitative)100134
긖ransferrin3130

2. 젙룄愿由щЪ吏덇낵 寃궗빆紐

젙룄愿由щЪ吏덉 Bio-Rad궗쓽 Lyphochek Immunossay Control (Bio-Rad Laboratories, Hercules, CA, USA) 벑 궗엺 삁泥쓣 湲곗쭏濡 븳 븸긽 젣뭹쓣 궗슜븯떎. 寃궗빆紐⑹ ceruloplasmin, ferritin, transferrin, haptoglobin, prealbumin, alpha1-antitrypsin, C-reactive protein, anti-streptolysin O, rheumatoid factor 벑 9媛쒖쑝硫, 씠 以 C-reactive protein怨 rheumatoid factor 벑 젙웾 諛 젙꽦 寃궗뿉 빐 anti-streptolysin O뒗 젙웾, 諛섏젙웾, 젙꽦 寃궗뿉 빐 떆뻾븯떎. 젙룄愿由щЪ吏덉쓣 닔졊븳 李몄뿬湲곌뿉꽌뒗 寃궗 떆뻾 썑 吏젙맂 쉶떊 留덇컧씪 씠궡뿉 븳엫긽寃궗젙룄愿由ы삊쉶 떊鍮숇룄議곗궗궗뾽 솃럹씠吏(http://eqas.keqas.org)뿉 寃곌낵瑜 엯젰븯룄濡 븯떎.

3. 寃곌낵 뙋젙 諛 遺꾩꽍

媛 湲곌뿉꽌 엯젰븳 寃궗빆紐⑸퀎 寃궗湲곌린, 떆빟, 寃궗寃곌낵뿉 뵲씪 넻怨꾨텇꽍쓣 떆뻾븯怨, 씠瑜 쟾泥 李몄뿬湲곌쓽 듅꽦쓣 蹂댁뿬二쇰뒗 怨듯넻蹂닿퀬꽌 媛쒕퀎湲곌쓽 룊媛옄猷뚮 蹂댁뿬二쇰뒗 湲곌蹂 蹂닿퀬꽌濡 굹늻뼱 蹂닿퀬븯떎. 怨듯넻蹂닿퀬꽌뒗 쟾泥 李몄뿬湲곌, 룞씪 옣鍮꾪쉶궗 궗슜湲곌, 룞씪 옣鍮 궗슜湲곌 벑 3떒怨꾨줈 洹몃9솕븯뿬 넻怨 媛믪쓣 젣떆븯떎(Fig. 1). 쟾泥 李몄뿬湲곌뿉 빐떦븯뒗 넻怨, 湲곌린쉶궗瑜 湲곗遺꾨쪟濡 븳 洹몃9쓽 넻怨, 듅젙 寃궗湲곌린濡 援щ텇븳 洹몃9쓽 넻怨꾨 媛곴컖 젣떆븯떎. 젣떆맂 넻怨꾩뿉뒗 媛 洹몃9蹂 李몄뿬湲곌 닔, 룊洹, 몴以렪李, 蹂룞怨꾩닔, 以묒븰媛, 理쒖냼媛, 理쒕媛 벑씠 룷븿릺뼱 엳떎. 李몄뿬湲곌 닔, 以묒븰媛, 理쒖냼媛믨낵 理쒕媛 벑 씠긽移섎 젣嫄고븯吏 븡 紐⑤뱺 李몄뿬湲곌쓽 닔移섎 젣떆븯쑝硫, 룊洹, 몴以렪李, 蹂룞怨꾩닔 벑 媛 洹몃9뿉꽌 씠긽移섎 젣嫄고븳 썑 궛異쒕맂 닔移섎줈 怨꾩궛븯떎. 븳렪, 룞씪 洹몃9뿉 냽븳 湲곌 닔媛 10媛 誘몃쭔씤 寃쎌슦뿉뒗 룊洹, 몴以렪李, 蹂룞怨꾩닔 벑쓣 젣떆븯吏 븡븯怨, 湲곌 닔媛 3媛 誘몃쭔씤 寃쎌슦뿉뒗 以묒븰媛믩룄 젣떆븯吏 븡븯떎. 씠긽移섎뒗 Tukey rule쓣 씠슜븯뿬 젣嫄고븯뒗뜲, 媛 빐떦 遺꾨쪟뿉꽌 75 percentile 媛(Q3)怨 25 percentile 媛(Q1)쓽 李(Q3-Q1; interquartile range, IQR)쓽 1.5諛곕 珥덇낵븯뿬 Q1蹂대떎 궙嫄곕굹 Q3蹂대떎 넂 寃곌낵媛(竊쏲1-1.5횞IQR 삉뒗 竊얫3+1.5횞IQR)쑝濡 꽕젙븯떎.

Figure 1.

Summary report of the general statistics report for the special protein proficiency testing program of the 2017 Korean External Quality Assessment Service.


媛쒕퀎湲곌蹂닿퀬꽌뒗 媛 寃궗빆紐⑸퀎濡 넻怨꾩튂瑜 蹂댁뿬二쇰뒗 몴, 엳뒪넗洹몃옩, 젅鍮-젣떇뒪 李⑦듃濡 援ъ꽦븯뿬 씪紐⑹슂뿰븯寃 蹂 닔 엳룄濡 븯떎(Fig. 2). 넻怨꾩튂瑜 젣떆븳 몴뿉뒗 媛 湲곌쓽 寃곌낵媛믨낵 媛 遺꾨쪟蹂 넻怨꾩튂瑜 젣떆븯怨 湲곗遺꾨쪟 꽭遺꾨쪟뿉꽌뒗 몴以렪李⑥닔(standard deviation index, SDI)瑜 븿猿 젣떆븯떎. 쟾泥 李몄뿬湲곌 옄猷뚯 媛 洹몃9蹂 李몄뿬湲곌쓽 닔媛 10媛 誘몃쭔씪 寃쎌슦뿉뒗 SDI瑜 젣떆븯吏 븡븯떎. 젅鍮-젣떇뒪 李⑦듃뒗 湲곗遺꾨쪟蹂 SDI瑜 씠슜븯뿬 옉꽦븯뒗뜲, 李몄뿬湲곌 닔媛 10媛 誘몃쭔씤 寃쎌슦뿉뒗 SDI媛 젣떆릺吏 븡븘꽌 젅鍮-젣떇뒪 李⑦듃뿉꽌룄 몴떆릺吏 븡븯떎. 엳뒪넗洹몃옩뿉꽌뒗 쟾泥 李몄뿬湲곌쓽 遺꾪룷 湲곗遺꾨쪟蹂 遺꾪룷瑜 젣떆븯怨 媛 湲곌쓽 쐞移섎 몴떆븯떎. 엳뒪넗洹몃옩쓽 泥 踰덉㎏ 留덉留 留됰뒗 媛곴컖 쟾泥 李몄뿬湲곌쓽 寃곌낵 遺꾪룷뿉꽌 2.5띁꽱씪 誘몃쭔怨 97.5띁꽱씪 씠긽뿉 빐떦븳떎.

Figure 2.

An example of an individual institutional report for the special protein proficiency testing program of the 2017 Korean External Quality Assessment Service.


寃곌낵 諛 怨좎같

떒諛깅㈃뿭寃궗봽濡쒓렇옩뿉꽌 100媛 씠긽쓽 湲곌씠 李몄뿬븯뒗 寃궗빆紐⑹ ferritin, C-reactive protein, anti-streptolysin O, rheumatoid factor 벑 4媛吏쑝硫, 굹癒몄 5빆紐⑹ 7-35湲곌쓽 李몄뿬 遺꾪룷瑜 蹂댁떎. 듅엳 alpha1-antitrypsin怨 anti-streptolysin O(諛섏젙웾) 寃궗뒗 쟾泥 李몄뿬湲곌씠 媛곴컖 7怨녠낵 4怨녹쑝濡 10湲곌뿉 誘몄튂吏 紐삵븯뿬 넻怨꾨텇꽍쓣 닔뻾븯吏 紐삵븯떎. 遺遺꾩쓽 빆紐⑹뿉꽌뒗 쟾뀈룄 鍮꾩듂븳 닔以쓽 李몄뿬湲곌 닔瑜 蹂댁吏留, C-reactive protein(젙웾) 寃궗뒗 2016뀈 1李 떊鍮숇룄議곗궗뿉꽌 359湲곌, 2017뀈 1李⑥뿉꽌 406湲곌, 2017뀈 2李⑥뿉꽌 464湲곌씠 李몄뿬븯뿬 李몄뿬湲곌 利앷 룺씠 겙 렪씠뿀떎. 젙꽦寃궗뒗 C-reactive protein, anti-streptolysin O, rheumatoid factor 벑 3媛 빆紐⑹뿉 빐 닔뻾븯怨, 紐⑤뱺 젙꽦寃궗빆紐⑹뿉꽌 1李⑥“궗蹂대떎 2李 議곗궗뿉꽌 李몄뿬湲곌쓽 닔媛 利앷븯떎.

젙웾寃궗빆紐⑸뱾뿉 빐 몢 李⑤쓽 떊鍮숇룄議곗궗뿉꽌 쟾泥 李몄뿬湲곌쓽 넻怨꾧컪쓣 Table 2뿉 젙由ы븯떎. 떒諛깅㈃뿭寃궗뒗 遺遺 쟾슜떆빟怨 湲곌린瑜 궗슜븯뒗뜲, 2李 떊鍮숇룄議곗궗뿉꽌 李몄뿬湲곌씠 464怨녹쑝濡 媛옣 留롮븯뜕 C-reactive protein(젙웾) 寃궗쓽 寃쎌슦, 18媛 쉶궗뿉꽌 63醫낅쪟쓽 寃궗옣鍮꾧 궗슜릺怨 엳뿀떎. C-reactive protein(젙웾) 寃궗쓽 쟾泥 湲곌 젙諛룄뒗 coefficient of variation (CV, %)媛 CP-17-04, -05, -06 臾쇱쭏뿉꽌 媛곴컖 9.8%, 6.8%, 5.9%濡 10% 씠궡瑜 蹂댁吏留, 理쒖냼媛믨낵 理쒕媛믪쓽 李⑥씠媛 臾댁쿃 겙 寃쎌슦媛 怨듯넻쟻쑝濡 愿李곕릺뿀떎. 2李 떊鍮숇룄議곗궗쓽 C-reactive protein(젙웾) CP-17-05 臾쇱쭏쓽 寃쎌슦, 464媛 쟾泥 李몄뿬湲곌쓽 CV (%)뒗 6.8%吏留, 理쒖냼媛믪씠 2.6 mg/dL, 理쒕媛믪씠 272 mg/dL濡 100諛 씠긽쓽 李⑥씠瑜 蹂댁쑝硫, 씠뒗 떎젣濡 寃궗寃곌낵媛 李⑥씠瑜 蹂댁떎湲곕낫떎뒗 寃궗寃곌낵 엯젰 삤瑜섏씠嫄곕굹 蹂닿퀬떒쐞瑜 李⑷컖븯뿬 諛쒖깮뻽쓣 寃껋쑝濡 異붿젙맂떎. C-reactive protein 寃궗寃곌낵瑜 SI unit (International System of Units, mg/L)쑝濡 蹂닿퀬븯젮硫 conventional unit (mg/dL)뿉 conversion factor씤 10쓣 怨깊빐빞 븯뒗뜲, 떊鍮숇룄議곗궗 寃곌낵 엯젰 떆 젙솗븳 떒쐞瑜 솗씤븯吏 븡怨 媛쒕퀎湲곌뿉꽌 痢≪젙맂 寃곌낵 떒쐞瑜 洹몃濡 엯젰븯뒗 寃쎌슦뿉 삤瑜섍 諛쒖깮븯寃 맂떎. 븳렪, 룞씪쉶궗 洹몃9씠굹 룞씪湲곌린 궗슜 洹몃9쓽 닽옄媛 쟻뼱꽌 寃곌낵 쟻빀꽦 뿬遺瑜 뙋떒븯뒗 SDI 벑 넻怨꾩옄猷뚮 遺꾩꽍븷 닔 뾾뒗 寃쎌슦媛 醫낆쥌 엳뿀뒗뜲, 씠윴 寃쎌슦뿉뒗 媛 湲곌뿉꽌 쟾泥 李몄뿬湲곌 옄猷 벑쓣 李멸퀬븯뿬 寃곌낵媛 뿀슜踰붿쐞뿉 뱶뒗吏 뿬遺瑜 媛쒕퀎쟻쑝濡 뙋떒븷 븘슂媛 엳寃좊떎.

Table 2 . Proficiency test results for quantitative special protein in 2017.

꺿꺿긖estNo. of participantsQuality control no.Mean짹standard deviationCoefficient of variation (%)Median (min뱈ax)
1st
귺lpha1-antitrypsin7CP-17-01NDND77 (7183)
CP-17-02NDND125 (115141)
CP-17-03NDND173 (154202)
귺nti-streptolysin O165CP-17-0171.38짹6.659.3272 (56100)
CP-17-02126.1짹9.017.14127.6 (99.5153.1)
CP-17-03334.84짹31.279.34325 (251.3415.5)
귽eruloplasmin14CP-17-0116.66짹0.623.7216.9 (15.318.4)
CP-17-0232.25짹1.464.5232.5 (28.634.1)
CP-17-0345.99짹2.395.245.5 (40.849.5)
귽-reactive protein406CP-17-010.55짹0.0611.670.6 (0.254)
CP-17-022.62짹0.197.242.6 (0.5268)
CP-17-034.76짹0.336.854.8 (0.5473)
긃erritin281CP-17-0131.7짹3.81233 (21445)
CP-17-02198.2짹39.419.9188 (118282)
CP-17-03315.6짹65.420.7298 (35459)
긅aptoglobin35CP-17-0168.8짹2.23.268 (6581)
CP-17-02154.4짹5.13.3154 (141182)
CP-17-03232.1짹9.24234 (204333)
긑realbumin26CP-17-0114.31짹0.815.6814.3 (12.915.8)
CP-17-0223.37짹1.054.4923.4 (21.327.2)
CP-17-0331.34짹2.16.731.6 (2838.1)
긓heumatoid factor334CP-17-0120.26짹1.738.5219.9 (10.457.6)
CP-17-0233.83짹3.239.5434 (1949.6)
CP-17-0346.26짹4.7610.346.1 (18.664)
긖ransferrin31CP-17-01162짹4.12.5163 (144177)
CP-17-02264.4짹11.84.5264 (240284)
CP-17-03361.1짹18.35.1358 (325401)
2nd
귺lpha1-antitrypsin7CP-17-04NDND77 (6778)
CP-17-05NDND127 (115138)
CP-17-06NDND178 (163221)
귺nti-streptolysin O168CP-17-0475.9짹5.917.878 (61135)
CP-17-05135.1짹8.196.1137.6 (101351)
CP-17-06312.1짹18.656315.5 (169559)
귽eruloplasmin14CP-17-0415.3짹1.531015.8 (12.419.9)
CP-17-0532짹26.332.8 (28.838.4)
CP-17-0645.8짹2.365.247.5 (41.157.5)
귽-reactive protein464CP-17-040.6짹0.069.80.6 (0.166)
CP-17-052.5짹0.176.82.6 (0.8272)
CP-17-065짹0.295.95.1 (1.5525)
긃erritin295CP-17-0433짹4.41335 (222,630)
CP-17-05163짹25.816162 (1001,258)
CP-17-06287짹51.418279 (1442,102)
긅aptoglobin35CP-17-0467짹1.9368 (6173)
CP-17-05150짹4.83152 (139261)
CP-17-06232짹7.83235 (169262)
긑realbumin24CP-17-0414.3짹0.644.414.4 (1225.3)
CP-17-0524.6짹1.24.924.8 (2134.1)
CP-17-0633.5짹2.056.133.1 (14.239.4)
긓heumatoid factor363CP-17-0420.4짹1.78.420.3 (0.928.3)
CP-17-0532.9짹3.139.533 (2.447.7)
CP-17-0644.9짹4.6210.345.7 (3.867.2)
긖ransferrin30CP-17-04155짹5.23157 (140274)
CP-17-05274짹11.14274 (251371)
CP-17-06364짹14.14365 (153422)

Abbreviation: ND, not determined.


븳렪, 諛섏젙웾 諛 젙꽦寃궗빆紐⑸뱾뿉 븳 쟾泥 李몄뿬湲곌쓽 넻怨꾧컪쓣 Table 3뿉 젙由ы븯떎. C-reactive protein(젙꽦) 몢 李⑤ 紐⑤몢 媛옣 궙 냽룄뿉꽌 빀쓽맂 寃곌낵瑜 룄異쒗븯吏 紐삵븯뒗뜲, 씠뒗 CP-17-01怨 CP-17-04 臾쇱쭏씠 0.5-0.6 mg/dL쓽 룊洹좉컪쓣 蹂댁湲곗뿉 뙋젙湲곗移(cutoff) 洹쇱쿂쓽 媛믪씠뼱꽌 씠윴 寃곌낵媛 굹솕쓣 寃껋쑝濡 異붿젙맂떎. Rheumatoid factor뒗 1李 떊鍮숇룄議곗궗뿉꽌 꽭 媛吏 젙룄愿由щЪ吏덉뿉 빐 紐⑤몢 빀쓽맂 寃곌낵瑜 씠걣뼱궡吏 紐삵븯吏留, 2李 떊鍮숇룄議곗궗뿉꽌뒗 CP-17-06 臾쇱쭏뿉 빐 positive 寃곌낵瑜 굹깉떎.

Table 3 . Proficiency test results for qualitative special protein in 2017.

꺿꺿긖estNo. of participantsQuality control no.Positive (%)Negative (%)
1st
귺nti-streptolysin O76CP-17-010100
CP-17-023.996.1
CP-17-0381.618.4
귽-reactive protein48CP-17-0147.952.1
CP-17-021000
CP-17-031000
긓heumatoid factor100CP-17-0143.057.0
CP-17-0265.035.0
CP-17-0370.030.0
2nd
귺nti-streptolysin O81CP-17-041.298.8
CP-17-0513.686.4
CP-17-0686.413.6
귽-reactive protein64CP-17-0450.050.0
CP-17-0596.93.1
CP-17-0698.41.6
긓heumatoid factor134CP-17-0464.235.8
CP-17-0548.551.5
CP-17-0695.54.5

떒諛깅㈃뿭 젙꽦/諛섏젙웾寃궗뿉 궗슜맂 媛곴컖쓽 젙룄愿由щЪ吏덉 젙웾寃궗뿉 궗슜맂 臾쇱쭏怨 룞씪븯誘濡, 젙꽦/諛섏젙웾寃궗濡 蹂닿퀬븯뒗 湲곌뿉꽌뒗 젙웾寃곌낵濡 蹂닿퀬븯뒗 쟾泥 李몄뿬湲곌쓽 룊洹좉낵 몴以렪李 벑쓽 넻怨꾧컪 諛 媛쒕퀎 젙꽦寃궗 떆빟쓽 cutoff 벑쓣 李멸퀬븯뿬 뙋떒븯뿬빞 븳떎. 삁瑜 뱾뼱, anti-streptolysin O CP-17-05 臾쇱쭏쓽 寃쎌슦, 쟾泥 李몄뿬湲곌 81怨녹쓽 寃곌낵뒗 86.4%媛 negative濡 쓳떟븯뿬 negative媛 젙떟씠뿀吏留, 룞씪 떆빟쉶궗蹂 遺꾨쪟뿉꽌뒗 TECO 궗(Anaheim, CA, USA) 젣뭹쓣 궗슜븳 14湲곌 以 negative濡 쓳떟븳 湲곌씠 78.6%濡 湲곌媛 빀쓽맂 寃곌낵瑜 씠걣뼱궡吏 紐삵븯떎. 씠 媛숈씠 쟾泥 李몄뿬湲곌쓽 뙋젙寃곌낵 룞씪떆빟/湲곌린 洹몃9쓽 뙋젙寃곌낵媛 씪移섑븯吏 븡嫄곕굹 寃곕줎쓣 궡吏 紐삵븯뒗 寃쎌슦뿉뒗 뿬윭 媛吏 긽솴쓣 怨좊젮븯뿬 寃곌낵瑜 떊以묓븯寃 빐꽍븷 븘슂媛 엳떎. 젙꽦寃궗쓽 寃쎌슦 룞씪븳 떆빟씠굹 옣鍮꾨 궗슜븯뒗 湲곌쓽 닔媛 쟻嫄곕굹 80% 씠긽쓽 빀쓽맂 寃곌낵媛 굹삤吏 븡뒗떎硫 젙떟쓣 뙋젙븯湲 뼱젮슫 寃쎌슦媛 엳뒗뜲, 吏냽쟻쑝濡 씠 媛숈 寃곌낵媛 굹삤뒗 떆빟뿉 빐꽌뒗 쉶궗굹 湲곌 李⑥썝뿉꽌 異붽 梨낆쓣 留덈젴븷 븘슂媛 엳쓣 寃껋쑝濡 깮媛곷맂떎.

2016뀈遺꽣 떒諛깅㈃뿭寃궗봽濡쒓렇옩 李⑥꽭 떊鍮숇룄議곗궗궗뾽 슫쁺諛⑹묠뿉 뵲씪 쟾 怨쇱젙씠 엫긽寃궗젙룄愿由ы삊쉶 以묒븰뿉꽌 씪愿 떆뻾릺뿀뒗뜲, 李몄뿬湲곌 씪遺 빆紐⑹뿉꽌 쟾뀈뿉 鍮꾪빐 긽떦엳 利앷븯쑝硫 룞猷 洹몃9씠 쟻 寃쎌슦뿉뒗 쇅遺젙룄愿由 寃곌낵瑜 떊以묓븯寃 빐꽍븷 븘슂媛 엳떎.

References
  1. Jun SH, Song J, Song WH. Clinical Chemistry Subcommittee, Korean Association of External Quality Assessment Service. Annual report on the external quality assessment scheme for clinical chemistry in Korea (2015). J Lab Med Qual Assur 2016;38:111-9.
    CrossRef
  2. Jun SH, Song J. Clinical Chemistry Subcommittee, The Korean Association of External Quality Assessment Service. Annual report on the external quality assessment scheme for clinical chemistry in Korea (2014). J Lab Med Qual Assur 2015;37:115-23.
    CrossRef
  3. Jun SH, Song J. Clinical Chemistry Subcommittee; The Korean Association of Quality Assurance for Clinical Laboratory. Annual report on the external quality assessment scheme in clinical chemistry in Korea (2013). J Lab Med Qual Assur 2014;36:113-21.
    CrossRef
  4. Lee YW, Jeon BR, Kim JG, Jun SH, Yun YM, Chun S, et al. Annual report on the external quality assessment scheme for routine clinical chemistry in Korea (2016). J Lab Med Qual Assur 2017;39:61-75.
    CrossRef